Abstract
Injection drug use (IDU) and IDU-related infectious diseases such as hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections are highly prevalent among prisoners worldwide. However, little is known about the prevalence of IDUs, HCV/HIV and the availability of respective treatment options in German prisons. Data provided by prison physicians of 31 prisons, representing 14,537 inmates, were included in this analysis. The proportion of IDUs among all prisoners was 21.9%. Substitution treatment was available in three out of four prisons (74.2%). Overall, 1137 substitution treatments were provided annually with a wide range of treatment aims. The prevalence rate was 14.3% for HCV and 1.2% for HIV. Around 5.5% of all HCV-infected prisoners were in antiviral treatment annually, 86.5% of all HIV-positive inmates in antiretroviral HIV-treatment. Generally, substitution treatment, and HCV and HIV testing and treatment are available. However, due to abstinence-orientated treatment aims, substitution treatment is rarely available as maintenance treatment, and HCV/HIV-treatment is mainly provided for patients with an existing treatment before imprisonment. The inconsistent data quality necessitates changes in prison-relate...Continue Reading
References
Mar 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jens ReimerMichael Krausz
Dec 24, 2005·Epidemiology and Infection·K StarkU Bienzle
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Barbara H McGovernGeorg M Lauer
Mar 15, 2008·Journal of Epidemiology and Community Health·M F VescioR Monarca
Citations
Feb 4, 2009·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·I I MichelsH Stöver
Jan 20, 2010·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·K KepplerJ Reimer
Jan 1, 2012·International Journal of Prisoner Health·Marc Lehmann
Jun 9, 2012·Substance Use & Misuse·Ingo Ilja Michels, Heino Stöver
Sep 7, 2016·BMC Public Health·Benjamin WenzUNKNOWN DRUCK Study group
Oct 27, 2017·BMC Public Health·Jana MüllerRuth Zimmermann
Mar 10, 2020·PloS One·Gyde SteffenSandra Dudareva
Sep 10, 2020·Frontiers in Psychiatry·Kira von BernuthAnnette Opitz-Welke
Oct 6, 2020·Frontiers in Public Health·Ida SperleSandra Dudareva
Jan 10, 2019·BMC Public Health·H StöverL Somaini
Mar 12, 2020·Substance Abuse Treatment, Prevention, and Policy·Kathrin BöhmerNorbert Scherbaum
Jan 16, 2019·Deutsches Ärzteblatt International·Annette Opitz-WelkeNorbert Konrad
Jun 18, 2021·Health Science Reports·Christoph SarrazinMarcus-Alexander Wörns
Nov 27, 2021·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Annemarie Rinder StengaardDorthe Raben